Focus: Luminate Medical is a publicly-listed Irish biotech focused on medical device solutions for chemotherapy-induced side effects, specifically alopecia and peripheral neuropathy. The company operates at a modest scale with 51-200 employees.
Profile data last refreshed 18h ago · AI intelligence enriched 2w ago
Best suited for early-career biotech professionals seeking device-side exposure and willing to accept execution risk in exchange for equity and hands-on responsibility.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Lead product addressing cosmetic quality-of-life burden in cancer patients; commercial stage unclear from available data.
Help build intelligence for Luminate Medical
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Luminate Medical's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Second device targeting significant oncology comorbidity with limited current therapeutic options.
Based on last 4 crawl cycles
Recent peer-reviewed publications with author affiliations at this company
Showing 5 of 7 publications
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo